Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Long-Term-Debt" stands at 39.41 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Johnson & Johnson's third quarter, the item "Total Long Term Debt" stands at 39.41 Billion USD. This represents an increase of 0.44 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 25.95 percent compared to the value the year prior.
The 1 year change in percent is 25.95.
The 3 year change in percent is 42.77.
The 5 year change in percent is 20.59.
The 10 year change in percent is 180.03.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Debt | 905,699,262,464.00 |
![]() | AbbVie Inc - Total Long Term Debt | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Debt | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Debt | 280,205,508,085.11 |
![]() | Novartis AG - Total Long Term Debt | 255,096,620,580.91 |